Atlas Trials

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Clinical trial NCT00107341 · COMPLETED

Trial details

NCT number
NCT00107341
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2005-08-01
Primary completion
2007-02-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.